IHC-plus(tm) FLT1 / VEGFR1 Antibody (N-Terminus)

LifeSpan BioSciences

IHC-plus(tm) FLT1 / VEGFR1 Antibody (N-Terminus)

23

Immunohistochemistry: The unconjugated form was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for the unconjugated form was determined to be 5-10 ug/ml.. IHC, IHC-P (5 - 10 µg/ml) Immunohistochemistry: The unconjugated form was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for the unconjugated form was determined to be 5-10 ug/ml.

ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.14 mg/ml

Unconjugated

FLT1

fms related receptor tyrosine kinase 1

FLT, FLT-1, VEGFR-1, VEGFR1, vascular endothelial growth factor receptor 1, fms related tyrosine kinase 1, fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), tyrosine-protein kinase FRT, tyrosine-protein kinase receptor FLT, vascular permeability factor receptor

Rabbit

Human

-20°C or -80°C,2°C to 8°C

41116161